Ascites.
- Author:
Soung Won JEONG
1
Author Information
- Publication Type:Review
- Keywords: Ascites; Liver cirrhosis; Hypertension portal
- MeSH: Ascites*; Diagnosis; Diuretics; Fibrosis; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Transplantation; Paracentesis; Portasystemic Shunt, Surgical; Prognosis; Renin-Angiotensin System; Sodium; Sympathetic Nervous System; Vasodilation
- From:The Korean Journal of Gastroenterology 2018;72(2):49-55
- CountryRepublic of Korea
- Language:Korean
- Abstract: Ascites is the most common cause of decompensation in cirrhosis, and 5% to 10% of patients with compensated cirrhosis develop ascites each year. The main factor of ascites formation is renal sodium retention due to activation of the renin-angiotensin-aldosterone system and sympathetic nervous system by the reduced effective volume secondary to splanchnic arterial vasodilation. Diagnostic paracentesis is indicated in all patients with a new onset of grade 2 or 3 ascites and in those admitted to hospital for any complication of cirrhosis. A serum-ascites albumin gradient of ≥1.1 g/dL indicates portal hypertension with an accuracy of approximately 97%. Sodium restriction, diuretics, and large volume paracentesis are the mainstay of treatment in grade 1 to 3 ascites. The refractoriness of ascites is associated with a poor prognosis with a median survival of approximately six months. Repeated large volume paracentesis plus albumin is the first line treatment, and liver transplantation is recommended in patients with refractory ascites. A careful selection of patients is also important to obtain the beneficial effects of transjugular intrahepatic portosystemic shunts in refractory ascites. This review details the recent diagnosis and treatment of cirrhotic ascites.
